Partnerships
KAIMRC Medical Biotechnology Park is launching a set of Innovation Programs dedicated to strategic partnerships with government, academic and industrial entities locally and globally with the aim to:
- Contribute to the ongoing transition of KSA economy from one based on natural resources to one based on knowledge and innovation with special emphasis on medical R&D
- Tackle diseases of highest incidence in the Kingdom of Saudi Arabia with global impact in order to be aligned with the national vision of providing excellent healthcare through innovation.
- Accelerate the set-up of applied Research and ensure a direct impact on patients care by setting up, a world-class medical R&D, biotechnology and biopharmaceutical hub at MNG-HA/KAIMRC.
- Rapidly build one of the world’s leading hubs for precision medicine in KSA.
Collaborations
![New Project (1) (8)](https://kaimrc-biotech.org.sa/wp-content/uploads/2023/06/New-Project-1-8.png)
Signing of an MoU with AstraZeneca in January 2019:
The objective is to develop capacity building and training program as well as develop joint clinical trials for diseases of interest to the Kingdom of Saudi Arabia.
![New Project (1) (9)](https://kaimrc-biotech.org.sa/wp-content/uploads/2023/06/New-Project-1-9.png)
Signing of an MoU with AstraZeneca in January 2019:
The objective is to develop capacity building and training program as well as develop joint clinical trials for diseases of interest to the Kingdom of Saudi Arabia.
![New Project (1) (1)](https://kaimrc-biotech.org.sa/wp-content/uploads/2023/06/New-Project-1-1.png)
Signing of an MoU with Roche in January 2019:
The objective is to develop capacity building and training program as well as develop joint clinical trials for diseases of interest to the Kingdom of Saudi Arabia.
![New Project (1) (2)](https://kaimrc-biotech.org.sa/wp-content/uploads/2023/06/New-Project-1-2.png)
Signing of an MoU with Hammersmith Medical Research Inc. in January 2019:
The objective is to develop capacity building and training program as well as the development of clinical trials management skills and pharmaceutical manufacturing capabilities in the Kingdom of Saudi Arabia.
![New Project (1) (4)](https://kaimrc-biotech.org.sa/wp-content/uploads/2023/06/New-Project-1-4.png)
Signing of an MoU with SABIC in January 2019:
The objective is to develop joint biomedical and health R&D and innovation projects in drug discovery and development.
![New Project (1) (5)](https://kaimrc-biotech.org.sa/wp-content/uploads/2023/06/New-Project-1-5.png)
Signing of an MoU with Moderna in January 2019:
The objective is to develop
……
![New Project (1) (6)](https://kaimrc-biotech.org.sa/wp-content/uploads/2023/06/New-Project-1-6.png)
Signing of an MoU with Pfizer in January 2019:
The objective is to develop
……
![New Project (1) (7)](https://kaimrc-biotech.org.sa/wp-content/uploads/2023/06/New-Project-1-7-1.png)
Signing of an MoU with Hevolution Foundation in January 2019:
The objective is to develop
……